DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,367 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $833,243 | +3.0% | 3,358 | -0.4% | 0.15% | +10.3% |
| Q2 2023 | $809,140 | -4.8% | 3,371 | 0.0% | 0.14% | -16.0% |
| Q1 2023 | $849,710 | -4.2% | 3,371 | +0.9% | 0.16% | -12.9% |
| Q4 2022 | $887,103 | +4.4% | 3,342 | +1.6% | 0.19% | -2.6% |
| Q3 2022 | $850,000 | +1.9% | 3,290 | 0.0% | 0.19% | +16.5% |
| Q2 2022 | $834,000 | -13.6% | 3,290 | 0.0% | 0.16% | +5.1% |
| Q1 2022 | $965,000 | -7.0% | 3,290 | +4.2% | 0.16% | -7.7% |
| Q4 2021 | $1,038,000 | +7.5% | 3,156 | -0.6% | 0.17% | -0.6% |
| Q3 2021 | $966,000 | +25.9% | 3,174 | +11.1% | 0.17% | +25.9% |
| Q2 2021 | $767,000 | +18.5% | 2,858 | -0.6% | 0.14% | +9.8% |
| Q1 2021 | $647,000 | -3.9% | 2,874 | -5.1% | 0.12% | -8.2% |
| Q4 2020 | $673,000 | -19.7% | 3,030 | -22.1% | 0.13% | -29.8% |
| Q3 2020 | $838,000 | +26.4% | 3,892 | +3.7% | 0.19% | +17.9% |
| Q2 2020 | $663,000 | +32.1% | 3,752 | +3.5% | 0.16% | +4.5% |
| Q1 2020 | $502,000 | -24.5% | 3,626 | -16.3% | 0.16% | +3.3% |
| Q4 2019 | $665,000 | +6.6% | 4,331 | +0.3% | 0.15% | -4.5% |
| Q3 2019 | $624,000 | 0.0% | 4,318 | -1.1% | 0.16% | +13.8% |
| Q2 2019 | $624,000 | -27.2% | 4,368 | -32.7% | 0.14% | -25.8% |
| Q1 2019 | $857,000 | +54.4% | 6,495 | +5.9% | 0.19% | +45.3% |
| Q4 2017 | $555,000 | +12.3% | 6,134 | +5.3% | 0.13% | -5.9% |
| Q2 2017 | $494,000 | – | 5,827 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |